From: Obstructive sleep apnea and nocturnal hypoxemia in adult patients with cystic fibrosis
 | ESS score ≥ 10 (n = 8) | ESS score < 10 (n = 44) | p value |
---|---|---|---|
Age, years | 28.9 ± 4.8 | 31.0 ± 8.4 | 0.718 |
AHI, events/h | 4.1 ± 3.2 | 4.7 ± 4.2 | 0.833 |
AHI REM, events/h | 7.7 ± 5.4 | 11.0 ± 10.9 | 0.970 |
AHI NREM, events/h | 3.2 ± 3.5 | 3.2 ± 3.5 | 0.872 |
ODI, events/h | 3.7 ± 2.7 | 4.7 ± 4.2 | 0.891 |
ODI REM, events/h | 7.6 ± 5.4 | 14.4 ± 23.7 | 0.694 |
ODI NREM, events/h | 2.7 ± 2.8 | 3.1 ± 3.6 | 0.911 |
Arousal index, events/h | 22.4 ± 8.2 | 18.1 ± 10.6 | 0.292 |
TST, min | 313.4 ± 29.0 | 297.7 ± 45.3 | 0.276 |
Sleep efficiency, % | 79.2 ± 8.4 | 74.6 ± 10.4 | 0.245 |
Sleep latency, min | 51.3 ± 20.7 | 71.2 ± 38.7 | 0.155 |
WASO, min | 30.8 ± 21.5 | 34.4 ± 29.2 | 0.813 |
Sleep stages, % TST | Â | Â | Â |
N1 | 2.8 ± 0.9 | 3.1 ± 1.9 | 0.970 |
N2 | 54.4 ± 5.4 | 50.2 ± 8.1 | 0.167 |
N3 | 21.9 ± 4.6 | 25.8 ± 9.3 | 0.375 |
REM | 18.6 ± 5.6 | 18.1 ± 6.6 | 0.833 |
Nocturnal mean SpO2, % | 92.4 ± 1.9 | 92.0 ± 2.4 | 0.718 |
Nocturnal minimum SpO2, % | 88.4 ± 3.0 | 86.7 ± 3.9 | 0.187 |
SpO2 < 90%, % TST | 7.9 ± 21.0 | 14.4 ± 28.3 | 0.133 |
SpO2 < 90, min | 23.0 ± 60.2 | 44.6 ± 89.5 | 0.097 |
Nocturnal respiratory rate, breaths/min | 20.5 ± 3.2 | 21.6 ± 4.1 | 0.478 |
Nocturnal heart rate, beats/min | 60.9 ± 7.0 | 68.5 ± 12.2 | 0.108 |
BMI, kg/m2 | 23.4 ± 2.6 | 21.1 ± 3.1 | 0.040 |
FEV1, L | 2.1 ± 0.8 | 2.1 ± 0.8 | 0.990 |
FEV1, % predicted | 52.0 ± 15.3 | 52.2 ± 14.9 | 0.978 |
FVC, L | 3.4 ± 1.2 | 3.4 ± 1.0 | 0.897 |
FVC, % predicted | 70.9 ± 18.8 | 69.3 ± 15.9 | 0.803 |
RV, L | 2.7 ± 0.6 | 3.1 ± 0.9 | 0.329 |
RV, % predicted | 172.8 ± 40.5 | 181.3 ± 42.5 | 0.603 |
Awake SpO2, % | 96.4 ± 1.1 | 95.7 ± 1.7 | 0.276 |
Awake pO2, mmHg | 78.0 ± 6.1 | 78.9 ± 9.4 | 0.789 |
Awake pCO2, mmHg | 38.4 ± 2.9 | 29.0 ± 2.8 | 0.591 |
Awake pH | 7.4 ± 0.02 | 7.4 ± 0.03 | 0.335 |
Awake HCO3−, mmol/L | 25.1 ± 1.3 | 24.6 ± 1.9 | 0.543 |